Condition

Alzheimer's Type

ClinicalTrials.gov condition label

Clinical trials3

Recruiting0

Common interventions2

Lead sponsors shown1

Clinical trials

3 shown

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or PlaceboNCT02192554 · 2014-06-01

COMPLETED

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's TypeNCT01922258 · 2013-09-01

COMPLETED

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationNCT01862640 · 2013-07-11

COMPLETED

Common interventions

Brexpiprazole, OPC-34712DRUG2Placebo Oral TabletDRUG1

Leading sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc.3

Trial status mix

COMPLETED3

Phase mix

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.